LINC-ROR and cancer: Some cholesterol intermediates or metabolites can act as ligands of ROR, and in that way the changes in cholesterol homeostasis have an impact on the transcriptional activity of ROR and finally can result in changes in the processes regulated by RORs, like immune responses, inflammation, cancer or several neurological disorders.